Charles R. Kummeth - Jun 14, 2021 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Chief Executive Officer, Director
Signature
/s/ Brenda S. Furlow as Attorney-in-Fact for Charles R. Kummeth pursuant to Power of Attorney previously filed.
Stock symbol
TECH
Transactions as of
Jun 14, 2021
Transactions value $
-$3,360,066
Form type
4
Date filed
6/16/2021, 07:22 PM
Previous filing
May 27, 2021
Next filing
Jun 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Sale -$3.2M -7.13K -4.09% $449.10* 167K Jun 14, 2021 Direct F1, F2, F3
transaction TECH Common Stock Sale -$157K -349 -0.21% $450.10* 167K Jun 14, 2021 Direct F1, F3
holding TECH Common Stock 100 Jun 14, 2021 By Step-Son
holding TECH Common Stock 100 Jun 14, 2021 By Step-Daughter

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TECH Stock Options (Right to Buy) 95.3K Jun 14, 2021 Common Stock 95.3K $108.49 Direct F4
holding TECH Stock Options (Right to Buy) 79.5K Jun 14, 2021 Common Stock 79.5K $108.49 Direct F4
holding TECH Stock Options (Right to Buy) 154K Jun 14, 2021 Common Stock 154K $106.59 Direct F4
holding TECH Stock Options (Right to Buy) 103K Jun 14, 2021 Common Stock 103K $106.59 Direct F4
holding TECH Stock Options (Right to Buy) 117K Jun 14, 2021 Common Stock 117K $125.05 Direct F4
holding TECH Stock Options (Right to Buy) 78.2K Jun 14, 2021 Common Stock 78.2K $125.05 Direct F6
holding TECH Restricted Stock Units 16.9K Jun 14, 2021 Common Stock 16.9K Direct F5, F7
holding TECH Stock Options (Right to Buy) 90.3K Jun 14, 2021 Common Stock 90.3K $177.32 Direct F7
holding TECH Stock Options (Right to Buy) 60.2K Jun 14, 2021 Common Stock 60.2K $177.32 Direct F8
holding TECH Restricted Stock Units 16.9K Jun 14, 2021 Common Stock 16.9K Direct F5, F9
holding TECH Stock Options (Right to Buy) 85.7K Jun 14, 2021 Common Stock 85.7K $190.41 Direct F9
holding TECH Stock Options (Right to Buy) 57.2K Jun 14, 2021 Common Stock 57.2K $190.41 Direct F10
holding TECH Restricted Stock Units 12.9K Jun 14, 2021 Common Stock 12.9K Direct F5, F11
holding TECH Stock Options (Right to Buy) 57.4K Jun 14, 2021 Common Stock 57.4K $267.87 Direct F11
holding TECH Stock Options (Right to Buy) 38.3K Jun 14, 2021 Common Stock 38.3K $267.87 Direct F12
holding TECH Stock Options (Right to Buy) 16.7K Jun 14, 2021 Common Stock 16.7K $267.87 Direct F13
holding TECH Stock Options (Right to Buy) 16.7K Jun 14, 2021 Common Stock 16.7K $267.87 Direct F14
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 18, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $449.00 to $449.97, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Includes (i) 3,759 shares of restricted stock for which the risk of forfeiture will lapse on August 8, 2021; (ii) 7,527 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on August 7, 2021 and as to 3,763 shares on August 7, 2022; and (iii) 8,586 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2021, August 5, 2022 and August 5, 2023.
F4 Fully exercisable.
F5 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F6 Options to purchase 19,557 shares vest on each of 8/9/2018, 8/9/2019, 8/9/2020 and 8/9/2021.
F7 Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8 Options to purchase 15,056 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 15,055 shares vest on each of 8/8/2021 and 8/8/2022.
F9 Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F10 Options to purchase 14,288 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 14,287 shares vest on each of 8/7/2022 and 8/7/2023.
F11 Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F12 Options to purchase 9,573 shares vest on 8/5/21 and options to purchase 9,574 shares vest on each of 8/5/22, 8/5/23 and 8/5/24.
F13 Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
F14 Options to purchase 5,550 shares vest on each of 8/5/21, 8/5/22 and 8/5/23.